Physician profile
Edward Cantu
NPI 1558528166
$73,947.96
in general payments reported to CMS, 2019-2025
4 companies · $42K in 2025
The $42K reported for 2025 was more than what 97% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $4,439 · 2023: $1,690 · 2024: $25K · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $59K · Travel and Lodging: $6,985 · Food and Beverage: $2,591 · Honoraria: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $58,933.00 |
| Travel and Lodging | $6,985.03 |
| Food and Beverage | $2,591.32 |
| Honoraria | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $65,706.65 | 2024-2025 | Steen Solution, Steen Solution |
| Csl Behring | $5,383.00 | 2022-2025 | |
| Xvivo Perfusion INC. | $1,641.04 | 2022-2025 | Xvivo Perfusion System (Xps) |
| Atricure, INC. | $1,217.27 | 2022-2025 | Atricure Cryoice Cryoablation System (Cryo2) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Cantu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.